1. Advanced Center for Chronic Diseases (ACCDiS), Facultad Ciencias Químicas y Farmacéuticas & Facultad Medicina (Y.F., G.Z.-T., A.N., L.A., C.H.-F., Z.P., M.C., M.J.K., S.L.), Centro de Modelamiento Molecular, Biofísica y Bioinformática (CM2B2).
2. Facultad Ciencias Químicas y Farmacéuticas (G.Z.-T., D.J.M.), Universidad de Chile, Santiago.
3. Instituto de Ciencias Biomédicas (ICBM), Facultad Medicina (G.S., Z.P., S.L.), Universidad de Chile, Santiago.
4. Departamento de Ciencias Químicas, Facultad de Ciencias Exactas, Universidad Andres Bello, Santiago, Chile (E.A.).
5. Núcleo de Biotecnología de Curauma (NBC), Pontificia Universidad Católica de Valparaíso, Chile (F.G.).
6. Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Spain (S.G., M.V., E.G.).
7. Department of Inorganic and Organic Chemistry, University of Barcelona, Spain (E.G.).
8. Department of Pharmacology (I.M., M.D.B., R.E.W.), Monash University, Clayton, VIC.
9. Cardiovascular Disease Program, Biomedicine Discovery Institute (I.M., M.D.B., R.E.W.), Monash University, Clayton, VIC.
10. Australia. Department of Neurobiology, University of Texas Medical Branch (UTMB), Galveston (S.V., E.A.E.).
11. Department of Internal Medicine (Cardiology Division) (J.A.H., S.L.), University of Texas Southwestern Medical Center, Dallas.
12. Department of Molecular Biology (J.A.H.), University of Texas Southwestern Medical Center, Dallas.
13. Harry S. Moss Heart Center (J.A.H.), University of Texas Southwestern Medical Center, Dallas.
14. Advanced Center for Chronic Diseases (ACCDiS), Facultad Medicina, Pontificia Universidad Católica de Chile, Santiago (M.P.O.).
15. Center of New Drugs for Hypertension and Heart Failure (CENDHY), División de Enfermedades Cardiovasculares, Pontificia Universidad Católica de Chile, Universidad de Chile, and Universidad Andrés Bello, Santiago (M.P.O.).